Forget Ozempic face… be wary of ‘Wegovy butt’! Weight loss jabs are leaving users with

It’s the blockbuster weight loss drug adored by Hollywood, despite being armed with powerful side effects. 

But now users of slimming jab semaglutide are warning about another unwelcome consequence — ‘Ozempic butt’. 

Slimmers who’ve lost up to 141lbs (64kg) claim they’ve been left with ‘saggy’ bums.

Others have complained about their derrières flattening like a ‘pancake’, including one who once underwent a Brazillian Bum Lift (BBL). 

The effects, albeit in the bum, are similar to those who’ve battled ‘Ozempic face’ — with the rapid weight loss leaving some users looking ill, exacerbating wrinkles and causing skin to sag.

The flab-busting drug doesn’t discriminate which weight it targets.

Videos highlighting the side effect by users themselves have racked up hundreds of thousands of views on TikTok. 

In one TikTok under the #ozempicbutt, watched 26,800 times, @jocelyngarcia3514 shared a full body video of her loose skin around her bum.

‘I’m humble enough to share my results and my body,’ she said.   

‘Keep in mind I had a BBL about seven years ago and this is what my butt looks like after my 16th injection of compound semaglutide,’ she added.  

‘What does an ozempic/semaglutide butt look like?,’ she also wrote. 

‘You guessed it? Loose skin and cellulite (nothing to brag about, results vary).’ 

Sharing a second video, she documented her weight loss dropping to 128lbs (58kg) from 143lbs (64.9kg), sharing before and after comparisons of using Ozempic.  

In another, @shellyslife365 told her TikTok followers: ‘At the beginning I was 285lbs (129.3kg) and now I’m only 144lbs (65.3kg).’

She added: ‘I’m almost at my goal weight, I have Ozempic Butt.

‘So now my butt is not this little round plump butt anymore. It’s flat and droopy like my chin. 

‘So my friends there is a thing called Ozempic butt. 

‘It will resolve itself after sometime, I truly hope.’ 

A third, @lynnesjourney also revealed she ‘had no butt left’ while using Mounjaro. 

This uses a similar drug to Ozempic, tirzepatide, mimicking certain natural appetite suppressing hormones. 

‘It’s all gone, now I’m stuck. I’ve lost all the fat in my b****,’ she said. 

‘I always said that if I ended up with saggy skin in my face, I’d have a facelift. But what am I going to do about my butt.’

Others took to TikTok comments to share their own experiences. 

‘I have Ozempic butt too, well, bariatric a**. Loose skin hanging on my a** from losing so much weight,’ @ramireztea wrote. 

Another commented, they were having the same issue ‘after losing weight fast from it’, while one agreed ‘I’m dealing with this! So sad’. 

But Dr Simon Cork, a senior lecturer in physiology at Anglia Ruskin University in Cambridge, told MailOnline: ‘This is essentially a sign that the drugs are working at reducing weight.’ 

He said: ‘The buttocks are one of the areas of the body where we deposit excess fat, more so in some people than others. 

‘So as people lose weight some people will see this come off their buttocks more than other areas.

‘Skin is like an elastic band. It stretches very easily, but the longer it is stretched the less likely it is to revert to its original size. 

‘This means that as people lose weight their skin stays stretched.’

He added: ‘It’s an unfortunate side effect of losing weight and many more people are likely to see this effect on their tummies, but it is a sign that Ozempic is having a positive effect on their weight.’

Semaglutide spurs on weight loss by mimicking the actions of a hormone released in the gut after eating — GLP-1.

As well as telling the pancreas to produce more insulin (hence why the drug is given to diabetics), GLP-1 also suppresses appetite, making us feel full. 

Elon Musk and Jeremy Clarkson have credited the drug for helping them lose weight.

Meanwhile, Kim Kardashian was rumoured to have used it to rapidly lose 16lbs (7.3kg) to fit into Marilyn Monroe’s dress at the 2022 Met Gala. 

Experts say the drug’s phenomenal success has driven a TikTok-fuelled stampede — with stocks now running dry across the world.

Despite being hailed as a miracle, trials have shown semaglutide users can rapidly pile pounds back on once they stop taking it.

Some patients have told of how they have had to stop taking the drug due to side effects. Users commonly complain about nausea, constipation and diarrhoea after taking the medication.

It has also been known to make food less appealing, potentially ruining the enjoyment of eating altogether.

The ‘Ozempic butt’ issue, however, has become so common that forum users are sharing their experiences of developing ‘saggy’ and ‘pancake’ bums in online chatrooms.  

In one Reddit group with over 39,000 members, one user wrote: ‘I’m down 28lbs so far… and I seriously think I lost most of it from my butt. It is a flat, saggy pancake now. Anyone else experiencing this? What are you doing to address it?’ 

In another thread titled ‘Does anyone think their butt is disappearing on Ozempic?’ a user said: ‘Yes I always had a good butt. And now it seems to have no volume and is saggy.’

On a separate group with over 16,000 members, one wrote: ‘Never have I lost as much fat in my a** as I have on Wegovy. 

‘I’ve ALWAYS had a decent sized a** through weight ups and downs, it’s consistently been the part of my body that I like…it’s practically a pancake now, it’s wild,’ they added. 

‘I’m seriously considering cosmetic surgery it’s that bad. With that said it’s still worth it to me.’

Wegovy was approved as a weight loss drug in the US in 2021 after clinical trials showed that alongside a diet and exercise regimen it could help a person lose 15 per cent of their weight over 68 weeks.

In March this year, NHS watchdog NICE also gave the green light for the weekly jab to be given in the UK for weight loss purposes. 

Wegovy will soon be available for people who have a BMI of 35 or more – a classification which means they are morbidly obese.

But earlier this week, the Government issued a blanket ban on wholesalers exporting some weight loss drugs, adding all forms of semaglutide to its parallel export ban list.

It means wholesalers are not allowed to buy stocks to sell them abroad, where they can drastically up the price.

Any company which breaches the export ban faces a punishment, handed out by the medicines watchdog.

Similar happened during the HRT crisis, when menopause-busting drugs were in short supply, and in the early days of the pandemic.

Dulaglutide, exenatide and liraglutide – which all work in the same way as semaglutide – are also on the export ban.

Latest NHS data shows 26 per cent of adults in England are obese and a further 38 per cent are overweight but not obese. One third of Americans are overweight, while four in ten are obese. 

Obesity rates have been on the rise for decades, with experts blaming sedentary lifestyles and unhealthy diets. 

They are also soaring in children, with a quarter of children in reception classes in England now considered overweight, and one in ten obese. 

A landmark study last month also revealed UK’s bulging waistline is stripping billions of pounds from the cash-strapped NHS each year, with twice as much spent on obese patients, as on those of a healthy weight.